ACOG 2024 recap: contraception, COVID-19 vaccination, and more

News
Article

Review some of the top stories from Contemporary OB/GYN's coverage of ACOG 2024, and catch up on anything you may have missed.

Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from ACOG 2024, and click each link to read and watch anything you may have missed.

1.) Meeting the contraceptive needs of transgender and gender nonbinary individuals

A symposium at ACOG 2024 focused on how to boost clinician confidence when it comes to contraception education for this patient population.

Click here for the full video.

2.) COVID-19 vaccination and its impact on menstrual cycles

Alison Edelman, MD, MPH, dives into her research presented at the 2024 ACOG Annual Clinical and Scientific Meeting on COVID-19 vaccination and it's impact on the menstrual cycle.

Click here for the full video.

3.) Buprenorphine use in pregnancy linked to decreased fetal breathing movements

According to a poster presented at ACOG 2024, use of the synthetic opioid buprenorphine depressed fetal breathing in biophysical profile assessments, but had no significant impact on other factors like amniotic fluid index or fetal tone.

Click here for the full article.

4.) Survey: State abortion access impacted OB/GYN residency applications

National survey data presented at ACOG 2024 shows many medical students applying for OB/GYN residencies prioritized states with abortion access.

Click here for the full article.

5.) New data shows elinzanetant's efficacy in treating menopausal symptoms

Phase 3 data presented by JoAnn Pinkerton, MD, reveals that elinzanetant significantly improves hot flash frequency, sleep, and overall menopause quality of life, offering a promising alternative to estrogen therapy.

Click here for the full article.

Recent Videos
March of Dimes 2024 Report highlights preterm birth crisis | Image Credit: marchofdimes.org
Understanding and managing postpartum hemorrhage: Insights from Kameelah Phillips, MD | Image Credit: callawomenshealth.com
Rossella Nappi, MD, discusses benefits of fezolinetant against vasomotor symptoms | Image Credit: imsociety.org
Understanding cardiovascular risk factors in women | Image Credit: cedars-sinai.org.
Updated FLUBLOK label expands influenza vaccine options for pregnant women | Image Credit: mass-vaccination-resources.org
JoAnn Pinkerton discusses elinzanetant's crucial role in VMS therapy | Image Credit: uvahealth.com
Empowering women to take charge of their health | Image Credit: © piecesofi.com - © piecesofi.com - stock.adobe.com.
Supporting women through menopause with knowledge and care | Image Credit: © SHOTPRIME STUDIO - © SHOTPRIME STUDIO - stock.adobe.com.
How fezolinetant revolutionizes non-hormonal menopause therapy | Image Credit: imsociety.org
Related Content
© 2024 MJH Life Sciences

All rights reserved.